HK1026372A1 - Treatment of chronic inflammatory diseases with cm101/gbs toxin - Google Patents

Treatment of chronic inflammatory diseases with cm101/gbs toxin

Info

Publication number
HK1026372A1
HK1026372A1 HK00105777A HK00105777A HK1026372A1 HK 1026372 A1 HK1026372 A1 HK 1026372A1 HK 00105777 A HK00105777 A HK 00105777A HK 00105777 A HK00105777 A HK 00105777A HK 1026372 A1 HK1026372 A1 HK 1026372A1
Authority
HK
Hong Kong
Prior art keywords
chronic inflammatory
treatment
inflammatory diseases
gbs toxin
toxin
Prior art date
Application number
HK00105777A
Other languages
English (en)
Inventor
Carl G Hellerqvist
Barbara D Wamil
Original Assignee
Carl G Hellerqvist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carl G Hellerqvist filed Critical Carl G Hellerqvist
Publication of HK1026372A1 publication Critical patent/HK1026372A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK00105777A 1997-01-29 2000-09-14 Treatment of chronic inflammatory diseases with cm101/gbs toxin HK1026372A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/790,989 US6028060A (en) 1997-01-29 1997-01-29 Treatment of chronic inflammatory diseases with CM101/GBS toxin
PCT/US1998/001852 WO1998032452A1 (fr) 1997-01-29 1998-01-29 Traitement des maladies inflammatoires chroniques par la toxine cm101/gbs

Publications (1)

Publication Number Publication Date
HK1026372A1 true HK1026372A1 (en) 2000-12-15

Family

ID=25152333

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105777A HK1026372A1 (en) 1997-01-29 2000-09-14 Treatment of chronic inflammatory diseases with cm101/gbs toxin

Country Status (12)

Country Link
US (2) US6028060A (fr)
EP (1) EP0981355B1 (fr)
JP (1) JP2001509797A (fr)
CN (1) CN1292759C (fr)
AT (1) ATE245991T1 (fr)
AU (1) AU6258898A (fr)
DE (1) DE69816807T2 (fr)
DK (1) DK0981355T3 (fr)
ES (1) ES2205450T3 (fr)
HK (1) HK1026372A1 (fr)
PT (1) PT981355E (fr)
WO (1) WO1998032452A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US8609614B2 (en) 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
US6803448B1 (en) 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
NZ702796A (en) 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
CA2947631A1 (fr) 2014-05-02 2015-11-05 Qu Biologics Inc. Immunomodulation anti-microbienne
US11267854B2 (en) 2016-07-20 2022-03-08 Westfaelische Wilhelms-Universitaet Muenster Complex-specific standardization of immunological methods for the quantification of S100A12

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US5010062A (en) * 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
US5382514A (en) * 1992-03-31 1995-01-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services In vivo angiogenesis assay
ATE348110T1 (de) * 1992-10-28 2007-01-15 Genentech Inc Hvegf rezeptor als vegf antagonist
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
BR9607427A (pt) * 1995-02-16 1998-06-23 Hoffmann La Roche Inibiçao de angiogêne usando interleucina 12
WO1997041844A1 (fr) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Combinaisons de composes angiostatiques
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin

Also Published As

Publication number Publication date
DK0981355T3 (da) 2003-11-10
DE69816807D1 (de) 2003-09-04
CN1292759C (zh) 2007-01-03
EP0981355A1 (fr) 2000-03-01
WO1998032452A1 (fr) 1998-07-30
AU6258898A (en) 1998-08-18
CN1251997A (zh) 2000-05-03
EP0981355B1 (fr) 2003-07-30
JP2001509797A (ja) 2001-07-24
US6476002B1 (en) 2002-11-05
PT981355E (pt) 2003-12-31
US6028060A (en) 2000-02-22
DE69816807T2 (de) 2004-04-15
ATE245991T1 (de) 2003-08-15
ES2205450T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
EP1366770A3 (fr) Utilisation de la toxine botulinique pour le traitement de la douleur liée à des troubles musculaires
MY113059A (en) Controlled-release dosage forms of azithromycin
EP0923293A4 (fr) Traitement contre la diarrhee
RO115700B1 (ro) Metodă de tratament cu interferon
GR3030418T3 (en) Method and compositions for the treatment of cerebral palsy.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
ES2168302T3 (es) Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e.
CA2141436A1 (fr) Traitement de la maladie d'alzheimer et modulation du systeme immunitaire par l'administration de delta-5-androstenes
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
EP2174662A3 (fr) Procédés pour traiter les blessures musculaires
GEP20002146B (en) Therapeutic Peptide Derivatives
WO2003092617A3 (fr) Combinaisons destinees au traitement de troubles cutanes inflammatoires
CA2158036A1 (fr) 3,4-diarylchromanes pour le traitement des dermatites
HK1026372A1 (en) Treatment of chronic inflammatory diseases with cm101/gbs toxin
DE69813200D1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
AU5323396A (en) Methods of treating inflammation and compositions therefor
IT1189298B (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
EP0445280A4 (en) Therapeutic agent and method of inhibiting vascularization of tumors
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
HK1015692A1 (en) Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections
HK1006947A1 (en) Treatment of liver cancer
AU4530796A (en) Treating disorders characterised by excessive cell proliferation with sclareolide
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
AU4042795A (en) Treatment of non-small cell lung carcinoma
WO1996029076A3 (fr) Traitement des affections instestinales inflammatoires par la cotinine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110129